Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of DC-806 Coadministered With Itraconazole or Carbamazepine in Healthy Participants
NCT05994807Phase 1Completed
- Sponsor
- DICE Therapeutics
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of navepdekinra (2 cohorts), sponsored by DICE Therapeutics. Primary endpoints: Maximum Observed Plasma Concentration at Day 18, Area Under the Concentration-Time Curve From Time Zero to the Last Measurable Concentration at Day 18 and 1 more. Started Aug 2023; status: completed.
02
Drugs
navepdekinra
Beyond the preview
Go deeper on NCT05994807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994807.